Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Discoid lupus erythematosus can be mistaken for a skin infection, complicating diagnosis and treatment.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Exosomes could revolutionize skin disease treatment and healing.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

New treatments and understanding of skin lupus are emerging in 2024.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

EpiLife® media and younger donor age improve artificial skin model quality.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.